Table 2.
Gray Matter ROI | HV (n = 27) | SCZ (n = 16) | Model | Diagnostic Effect | Genetic Effect | Age Effect | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adjusted Mean | SE | Adjusted Mean | SE | F (3,39) | P | F (1,39) | P | F (1,39) | P | F (1,39) | P | ||
V T | Hippocampus | 11.45 | 2.03 | 8.03 | 2.65 | 1.501 | .230 | 1.045 | .313 | 1.801 | .187 | 0.997 | .324 |
Medial prefrontal cortex | 9.03 | 0.52 | 9.69 | 0.67 | 5.968 | .002 | 0.602 | .442 | 15.606 | <.001 | 1.012 | .321 | |
Temporal cortex | 9.59 | 0.60 | 9.78 | 0.78 | 5.101 | .004 | 0.037 | .847 | 14.173 | .001 | 0.394 | .534 | |
Dorsolateral prefrontal cortex | 9.51 | 0.57 | 9.83 | 0.76 | 4.521 | .008 | 0.110 | .742 | 11.472 | .002 | 1.120 | .296 | |
Striatum | 8.17 | 0.47 | 8.38 | 0.61 | 6.151 | .002 | 0.075 | .786 | 18.443 | <.001 | 0.307 | .583 | |
V T, corrected for partial volume effect | Hippocampus | 13.08 | 2.02 | 9.19 | 2.63 | 1.570 | .212 | 1.374 | .249 | 2.227 | .144 | 0.473 | .496 |
Medial prefrontal cortex | 13.10 | 0.77 | 13.76 | 1.00 | 5.460 | .003 | 0.274 | .604 | 15.869 | <.001 | 0.057 | .813 | |
Temporal cortex | 12.39 | 0.75 | 12.24 | 0.98 | 5.152 | .004 | 0.014 | .907 | 14.878 | <.001 | 0.034 | .854 | |
Dorsolateral prefrontal cortex | 13.90 | 0.84 | 13.56 | 1.10 | 3.905 | .016 | 0.062 | .804 | 11.397 | .002 | 0.028 | .869 | |
Striatum | 8.903 | 0.54 | 9.03 | 0.70 | 6.900 | .001 | 0.020 | .888 | 20.652 | <.001 | 0.230 | .634 | |
White Matter ROI | HV (n = 27) | SCZ (n = 15) | F (3,38) | P | F (3,38) | P | F (3,38) | P | F (3,38) | P | |||
V T | Corpus callosum | 7.05 | 0.82 | 6.05 | 1.10 | 1.127 | .350 | 0.521 | .475 | 2.071 | .158 | 0.299 | .588 |
Cingulum | 8.60 | 1.06 | 7.37 | 1.43 | 2.066 | .121 | 0.482 | .492 | 3.414 | .072 | 1.371 | .249 | |
SLF | 7.37 | 0.63 | 6.52 | 0.85 | 1.624 | .200 | 0.641 | .428 | 2.559 | .118 | 0.911 | .346 | |
PLIC | 7.57 | 0.56 | 7.22 | 0.74 | 2.314 | .092 | 1.208 | .149 | 6.406 | .016 | 0.400 | .531 |
Note: Factorial ANOVA comparisons were performed for each ROI to compare differences between diagnostic groups, with genotype (HAB vs MAB) and age added as covariates. White matter data obtained from one subject from the SCZ group was excluded, since no reliable kinetic model fit could be achieved in the white matter ROIs (coefficient of variation [COV] > 50). [18F]-FEPPA, N-acetyl-N-(2-[18F]fluoroethoxybenzyl)-2-phenoxy-5-pyridinamine; HAB, high-affinity binder; MAB, mixed-affinity binder; PLIC, posterior limb of the internal capsule; ROI, regions of interest; SLF, superior longitudinal fasciculus. Significant values are provided in bold.